ARCHIVES

Community Based Organizing Nearly Complete; Conn. Still Planning

This article is from The Cancer Letter archive.

Vol. 03 No. 47 | November 25, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Administration Seeks Increase In FDA Budget.

June 13, 2008